Health Condition 1: M45-M49- Spondylopathies
Conditions
Interventions
Intervention1: PLATELET RICH PLASMA
: USG guided injection of PLATELET RICH PLASMA 1.5 ml in Paratendinous halo of
Achilles tendon
Control Intervention1: Triamcilone acetonide: USG guided injection
Sponsors
Dr Parasar ghosh
Eligibility
Inclusion criteria
Inclusion criteria: Patients with spondyloarthritides (SpA) satisfying the ASAS criteria for classification of axial spondyloarthritis or psoriatic arthritis (CASPAR criteria). Presence of clinically symptomatic and high resolution USG proven tendoAchilles enthesitis. Willing and able to give informed consent for participation Age >=16 years Able and willing to comply with all study requirements Able to attend the 12-week follow-up at IPGMER.
Exclusion criteria
Exclusion criteria: diabetes mellitus Evidence of lower limb gangrene/ulcers or peripheral vascular disease Pregnant or breast feeding On anticoagulant History of previous peritenidnous injection within the past 3 months Acute tendon injury History of tendon rupture or surgery Inability to comply to 24 hours of absolute bed-rest post procedure
Design outcomes
Secondary
| Measure | Time frame |
|---|---|
| 1.Achilles Tendon Rupture Score; Timepoint(s): 6 and 12 week 2.VISA-A score after 6 and 12 weeks 3.Ultrasound assessment(0 and 12 weeks) ï?? Median entheseal thickness in mm (range) ï?? Entheseal hypoechogenicity ï?? Peritendinous oedema ï?? Bursitis ï?? Median entheseal Power Doppler signal (0â??3 scale) ï?? Median bursal Power Doppler signal (0â??3 scale Timepoint: 6 weeks and 12 weeks | — |
Primary
| Measure | Time frame |
|---|---|
| Fall of VAS pain from baselineTimepoint: 12 weeks | — |
Countries
India
Contacts
Public ContactPrashant Dudhagara
Institute of Post graduate Medical Education & Research
Outcome results
None listed